Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Stifel Adjusts Medtronic's Price Target to $140 from $145, Keeps Buy Rating

11/24/2021 | 12:07pm EST


ę MT Newswires 2021
All news about MEDTRONIC PLC
01/14Medtronic Says Data From DTM Spinal Cord Stimulation Endurance Therapy Study Shows Mean..
MT
01/14Medtronic announces results showing meaningful pain relief using DTM™ Spinal Cord..
AQ
01/14Medtronic plc Announces Three-Month Results from an On-Label, Prospective, Multi-Center..
CI
01/12Medtronic announces schedule for presentations at the 2022 North American Neuromodulati..
AQ
01/10Medtronic Secures Japanese Regulator Nod for Micra AV Transcatheter Pacing System
MT
01/10Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter P..
PR
01/10Medtronic Announces Regulatory Approval and Launch in Japan of Micra AV Transcatheter P..
CI
01/10Medtronic's Transcatheter Aortic Valve Replacement System Receives Approval In China
MT
01/10Medtronic to Buy Medical Technology Firm Affera For Undisclosed Sum
MT
01/10BTIG Downgrades Medtronic to Neutral from Buy
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 365 M - -
Net income 2022 5 437 M - -
Net Debt 2022 21 581 M - -
P/E ratio 2022 27,1x
Yield 2022 2,31%
Capitalization 146 B 146 B -
EV / Sales 2022 5,18x
EV / Sales 2023 4,82x
Nbr of Employees 90 000
Free-Float -
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 108,55 $
Average target price 130,50 $
Spread / Average Target 20,2%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC4.93%145 952
ABBOTT LABORATORIES-8.94%219 790
BECTON, DICKINSON AND COMPANY4.43%74 858
HOYA CORPORATION-10.96%49 369
DEXCOM, INC.-16.69%43 357
BAXTER INTERNATIONAL INC.0.06%42 929